| Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. AM Henney, PR Wakeley, MJ Davies, K Foster, R Hembry, G Murphy, ... Proceedings of the National Academy of Sciences 88 (18), 8154-8158, 1991 | 830 | 1991 |
| Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. PA Crossey, FM Richards, K Foster, JS Green, A Prowse, F Latif, ... Human Molecular Genetics 3 (8), 1303-1308, 1994 | 433 | 1994 |
| Somatic mutations of the von Hippel—Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma K Foster, A Prowse, A van den Berg, S Fleming, MMF Hulsbeek, ... Human molecular genetics 3 (12), 2169-2173, 1994 | 428 | 1994 |
| Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours PA Crossey, K Foster, FM Richards, ME Phipps, F Latif, K Tory, MH Jones, ... Human genetics 93, 53-58, 1994 | 177 | 1994 |
| Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer H Foster, PS Sharp, T Athanasopoulos, C Trollet, IR Graham, K Foster, ... Molecular therapy 16 (11), 1825-1832, 2008 | 140 | 2008 |
| Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22 K Foster, PA Crossey, P Cairns, JW Hetherington, FM Richards, ... British journal of cancer 69 (2), 230-234, 1994 | 127 | 1994 |
| Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice A Malerba, PS Sharp, IR Graham, V Arechavala-Gomeza, K Foster, ... Molecular Therapy 19 (2), 345-354, 2011 | 103 | 2011 |
| Detailed mapping of germline deletions of the von Hippel—Lindau disease tumour suppressor gene FM Richards, PA Crossey, ME Phlpps, K Foster, F Latif, G Evans, ... Human molecular genetics 3 (4), 595-598, 1994 | 99 | 1994 |
| Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice A Matsakas, K Foster, A Otto, R Macharia, MI Elashry, S Feist, I Graham, ... Neuromuscular Disorders 19 (7), 489-499, 2009 | 95 | 2009 |
| Gene therapy progress and prospects: Duchenne muscular dystrophy K Foster, H Foster, JG Dickson Gene therapy 13 (24), 1677-1685, 2006 | 95 | 2006 |
| Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres C Trollet, SY Anvar, A Venema, IP Hargreaves, K Foster, A Vignaud, ... Human molecular genetics 19 (11), 2191-2207, 2010 | 92 | 2010 |
| Mapping the Von Hippel—Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis FM Richards, ME Phipps, F Latlf, M Yao, PA Crossey, K Foster, ... Human molecular genetics 2 (7), 879-882, 1993 | 76 | 1993 |
| Antisense-induced myostatin exon skipping leads to muscle hypertrophy in mice following octa guanidine morpholino oligomer treatment JK Kang, A Malerba, L Popplewell, K Foster, G Dickson Molecular therapy 19 (1), 159-164, 2011 | 74 | 2011 |
| Immune responses, not promoter inactivation, are responsible for decreased long-term expression following plasmid gene transfer into skeletal muscle KE Wells, J Maule, R Kingston, K Foster, J McMahon, E Damien, A Poole, ... FEBS letters 407 (2), 164-168, 1997 | 68 | 1997 |
| Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level … T Koo, A Malerba, T Athanasopoulos, C Trollet, L Boldrin, A Ferry, ... Human gene therapy 22 (11), 1379-1388, 2011 | 63 | 2011 |
| Genetic linkage between Von Hippel—Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus PA Crossey, ER Maher, MH Jones, FM Richards, F Latif, ME Phipps, ... Human molecular genetics 2 (3), 279-282, 1993 | 58 | 1993 |
| Enhanced exercise and regenerative capacity in a mouse model that violates size constraints of oxidative muscle fibres S Omairi, A Matsakas, H Degens, O Kretz, KA Hansson, AV Solbrå, ... Elife 5, e16940, 2016 | 57 | 2016 |
| Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal ME Cleasby, S Jarmin, W Eilers, M Elashry, DK Andersen, G Dickson, ... American Journal of Physiology-Endocrinology and Metabolism 306 (7), E814-E823, 2014 | 53 | 2014 |
| Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle K Foster, IR Graham, A Otto, H Foster, C Trollet, PJ Yaworsky, FS Walsh, ... Rejuvenation research 12 (2), 85-94, 2009 | 50 | 2009 |
| Description of a dinucleotide repeat polymorphism in the human elastin gene and its use to confirm assignment of the gene to chromosome 7 K Foster, R Ferrell, L King‐Underwood, S Povey, J Attwood, R Rennick, ... Annals of human genetics 57 (2), 87-96, 1993 | 43 | 1993 |
